Results 111 to 120 of about 11,782,455 (235)

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation

open access: yes, 2002
BACKGROUND: Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself. It is now a well-recognised cause
Elias, Elwyn   +5 more
core   +4 more sources

Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.

open access: yes, 2007
Non-alcoholic fatty liver disease is a condition charactrerised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake. Some patients develop non alcoholic steatohepatitis.
ORLANDO, ROCCO   +7 more
core   +1 more source

Prevalence of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and the degree of steatosis according to the presence of Hellicobacter Pylori infection in the subgroup of 93 patients with both gastric and liver biopsies.

open access: yes, 2016
HP: Helicobacter Pylori; NAFLD: non-alcoholic fatty liver disease; NASH: non-alcoholic steatohepatitis.
Andreea Ciudin (420822)   +11 more
core   +1 more source

Effect of diet on the development of liver damage of non-alcoholic steatohepatitis in mice

open access: yes, 2023
CHARLES UNIVERSITY Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Bioanalytical laboratory diagnostics in healthcare Diploma thesis Author: Bc. Amálie Hemmerová Supervisor: PharmDr. Jana Rathouská, Ph.D. Title: Effect
Hemmerová, Amálie
core  

The therapeutic landscape of non-alcoholic steatohepatitis. [PDF]

open access: yes, 2016
Non-alcoholic steatohepatitis (NASH) is characterized by lobular inflammation and hepatocellular ballooning, and may be associated with liver fibrosis leading to cirrhosis and its complications.
Perazzo, Hugo   +6 more
core   +1 more source

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis

open access: yesIbrain, Volume 11, Issue 1, Page 74-83, Spring 2025.
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley   +1 more source

Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis

open access: yesAnimal Models and Experimental Medicine
Background Nonalcoholic steatohepatitis (NASH) is characterized by liver steatosis, inflammation, and even fibrosis. NASH is likely to develop into cirrhosis and liver cancer, the major causes of liver related deaths.
Donglin Liu, Pengguo Chen
doaj   +1 more source

Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?

open access: yes, 2012
Background Non-alcoholic fatty liver disease (NAFLD) is currently conceptualised as a clinical spectrum that results from a 'multiple-hit' process which begins with simple steatosis and subsequently renders the hepatocytes susceptible to a ...
Y. Yilmaz, YILMAZ, YUSUF
core   +1 more source

Physical Activity and Risk of Liver Cancer: A Competing Risk Analysis

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Physical activity is associated with lower risk of liver cancer, but obtaining an unbiased estimate of the causal effect is challenging due to the competing risk of death due to any other cause. We performed a causal competing risk analysis to estimate the total effect of physical activity on risk of liver cancer in the presence of competing ...
Frances E. M. Albers   +9 more
wiley   +1 more source

Probiotics and intestinal permeability in adults with metabolic dysfunction‐associated steatohepatitis: A secondary analysis of a randomized clinical trial

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with altered intestinal permeability, allowing microbial products to translocate to the liver via the enterohepatic circulation and contributes to disease progression. The aim of our study was to evaluate the association between probiotic supplementation and serum
Bruna Concheski de Moura   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy